Abstract:Tumor microenvironment is considered nowadays as one of the main players in cancer development and progression. Tumor microenvironment is highly complex and consists of non-tumor cells (i.e., cancer-associated fibroblast, endothelial cells, or infiltrating leukocytes) and a large list of extracellular matrix proteins and soluble factors. The way that microenvironment components interact among them and with the tumor cells is very complex and only partially understood. However, it is now clear that these interactions govern and modulate many of the cancer hallmarks such as cell proliferation, the resistance to death, the differentiation state of tumor cells, their ability to migrate and metastasize, and the immune response against tumor cells. One of the microenvironment components that have emerged in the last years with strength is a heterogeneous group of multifaceted proteins grouped under the name of matricellular proteins. Matricellular proteins are a family of non-structural matrix proteins that regulate a variety of biological processes in normal and pathological situations. Many components of this family such as periostin (POSTN), osteopontin (SPP1), or the CNN family of proteins have been shown to regulate key aspect of tumor biology, including proliferation, invasion, matrix remodeling, and dissemination to pre-metastatic niches in distant organs. Matricellular proteins can be produced by tumor cells themselves or by tumor-associated cells, and their synthesis can be affected by intrinsic and/or extrinsic tumor cell factors. In this review, we will focus on the role of POSTN in the development and progression of cancer. We will describe their functions in normal tissues and the mechanisms involved in their regulation. We will analyze the tumors in which their expression is altered and their usefulness as a biomarker of tumor progression. Finally, we will speculate about future directions for research and therapeutic approaches targeting POSTN.

Periostin: a bridge between cancer stem cells and their metastatic niche.

Roles of periostin in cancer

Periostin expression in intra-tumoral stromal cells is prognostic and predictive for colorectal carcinoma via creating a cancer-supportive niche.

Periostin: a putative mediator involved in tumour resistance to anti-angiogenic therapy?

Periostin Promotes Immunosuppressive Premetastatic Niche Formation to Facilitate Breast Tumour Metastasis.

Cancer Stem Cell-Related Gene Periostin: A Novel Prognostic Marker For Breast Cancer

Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway.

The Multifaceted Role of Periostin in Priming the Tumor Microenvironments for Tumor Progression.

Periostin Contributes to the Acquisition of Multipotent Stem Cell-Like Properties in Human Mammary Epithelial Cells and Breast Cancer Cells.

The Multiaspect Functions of Periostin in Tumor Progression.

Research of Periostin in Cancer

Periostin, a Multifunctional Matricellular Protein in Inflammatory and Tumor Microenvironments

Periostin Secreted by Carcinoma-Associated Fibroblasts Promotes Ovarian Cancer Cell Platinum Resistance Through the PI3K/Akt Signaling Pathway.

The multifaceted role of periostin in tumorigenesis

TGFβ3-mediated Induction of Periostin Facilitates Head and Neck Cancer Growth and is Associated with Metastasis

Periostin: A Matricellular Protein With Multiple Functions in Cancer Development and Progression

Periostin Promotes Colorectal Tumorigenesis Through Integrin-FAK-Src Pathway-Mediated YAP/TAZ Activation

Periostin, Secreted from Stromal Cells, Has Biphasic Effect on Cell Migration and Correlates with the Epithelial to Mesenchymal Transition of Human Pancreatic Cancer Cells

Periostin Secreted from Podoplanin-Positive Cancer-Associated Fibroblasts Promotes Metastasis of Gastric Cancer by Regulating Cancer Stem Cells Via AKT and YAP Signaling Pathway.

Periostin, a Matrix Specific Protein, is Associated with Proliferation and Invasion of Pancreatic Cancer

Acquired Expression of Periostin by Human Breast Cancers Promotes Tumor Angiogenesis Through Up-Regulation of Vascular Endothelial Growth Factor Receptor 2 Expression.